1
|
Zadnorouzi M, Abtahi SMM. Artificial intelligence (AI) applications in improvement of IMRT and VMAT radiotherapy treatment planning processes: A systematic review. Radiography (Lond) 2024; 30:1530-1535. [PMID: 39321595 DOI: 10.1016/j.radi.2024.09.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2024] [Revised: 07/11/2024] [Accepted: 09/06/2024] [Indexed: 09/27/2024]
Abstract
INTRODUCTION Radiotherapy is a common option in the treatment of many types of cancer. Intensity-Modulated Radiation Therapy (IMRT) and Volumetric-Modulated Arc Therapy (VMAT) are the latest radiotherapy techniques. However, clinicians face problems due to these techniques' complexity and time-consuming planning. Various studies have pointed out the importance and role of artificial intelligence (AI) in radiotherapy and accelerating and improving its quality. This research explores different AI methods in different fields of IMRT and VMAT. This study evaluated both quantitative and qualitative methods used within the reviewed articles. METHODS Various articles were reviewed from Google Scholar, Science Direct, and PubMed databases between 2018 and 2024. According to PRISMA 2020 guidelines, study selection processes, screening, and inclusion and exclusion criteria were defined. The critical Appraisal Skill Program qualitative checklist tool was used for the qualitative evaluation of articles. RESULTS 26 articles met the inclusion among the 33 articles obtained. The search procedure was displayed using the PRISMA flow diagram. The evaluation of the articles shows the automation of various treatment planning processes by AI methods and their better performance than traditional methods. The qualitative evaluation of studies has demonstrated the high quality of all studies. The lowest score obtained from the qualitative evaluation of the article is 7 out of 9. CONCLUSION AI methods used in radiotherapy reduce time and increase prediction accuracy. They also work better than other methods in different areas, such as dose prediction, treatment design, and dose delivery. IMPLICATIONS FOR PRACTICE Healthcare providers should consider integrating artificial intelligence technologies into their practice to optimize treatment planning and enhance patient care in radiation therapy. Additionally, fostering collaboration between radiotherapy experts and artificial intelligence specialists can significantly improve the development and application of AI technologies in this field.
Collapse
Affiliation(s)
- M Zadnorouzi
- Department of Physics, University of Guilan, Rasht, Iran
| | - S M M Abtahi
- Physics Department, Imam Khomeini International University, Qazvin, Iran.
| |
Collapse
|
2
|
Rowan NJ. Digital technologies to unlock safe and sustainable opportunities for medical device and healthcare sectors with a focus on the combined use of digital twin and extended reality applications: A review. THE SCIENCE OF THE TOTAL ENVIRONMENT 2024; 926:171672. [PMID: 38485014 DOI: 10.1016/j.scitotenv.2024.171672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 03/09/2024] [Accepted: 03/10/2024] [Indexed: 03/26/2024]
Abstract
Medical devices have increased in complexity where there is a pressing need to consider design thinking and specialist training for manufacturers, healthcare and sterilization providers, and regulators. Appropriately addressing this consideration will positively inform end-to-end supply chain and logistics, production, processing, sterilization, safety, regulation, education, sustainability and circularity. There are significant opportunities to innovate and to develop appropriate digital tools to help unlock efficiencies in these important areas. This constitutes the first paper to create an awareness of and to define different digital technologies for informing and enabling medical device production from a holistic end-to-end life cycle perspective. It describes the added-value of using digital innovations to meet emerging opportunities for many disposable and reusable medical devices. It addresses the value of accessing and using integrated multi-actor HUBs that combine academia, industry, healthcare, regulators and society to help meet these opportunities. Such as cost-effective access to specialist pilot facilities and expertise that converges digital innovation, material science, biocompatibility, sterility assurance, business model and sustainability. It highlights the marked gap in academic R&D activities (PRISMA review of best publications conducted between January 2010 and January 2024) and the actual list of U.S. FDA's approved and marketed artificial intelligence/machine learning (AI/ML), and augmented reality/virtual reality (AR/VR) enabled-medical devices for different healthcare applications. Bespoke examples of benefits underlying future use of digital tools includes potential implementation of machine learning for supporting and enabling parametric release of sterilized products through efficient monitoring of critical process data (complying with ISO 11135:2014) that would benefit stakeholders. This paper also focuses on the transformative potential of combining digital twin with extended reality innovations to inform efficiencies in medical device design thinking, supply chain and training to inform patient safety, circularity and sustainability.
Collapse
Affiliation(s)
- Neil J Rowan
- Centre for Sustainable Disinfection and Sterilization, Technological University of the Shannon, Midlands Campus, Ireland; CURAM SFI Research Centre for Medical Devices, University of Galway, Ireland.
| |
Collapse
|
3
|
Currie GM, Rohren EM. Radiation Dosimetry, Artificial Intelligence and Digital Twins: Old Dog, New Tricks. Semin Nucl Med 2023; 53:457-466. [PMID: 36379728 DOI: 10.1053/j.semnuclmed.2022.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 10/28/2022] [Indexed: 11/14/2022]
Abstract
Developments in artificial intelligence, particularly convolutional neural networks and deep learning, have the potential for problem solving that has previously confounded human intelligence. Accurate prediction of radiation dosimetry pre-treatment with scope to adjust dosing for optimal target and non-target tissue doses is consistent with striving for improved the outcomes of precision medicine. The combination of artificial intelligence and production of digital twins could provide an avenue for an individualised therapy doses and enhanced outcomes in theranostics. While there are barriers to overcome, the maturity of individual technologies (i.e. radiation dosimetry, artificial intelligence, theranostics and digital twins) places these approaches within reach.
Collapse
Affiliation(s)
- Geoffrey M Currie
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, TX.
| | - Eric M Rohren
- Charles Sturt University, NSW, Australia; Baylor College of Medicine, TX
| |
Collapse
|
4
|
Tryggestad E, Anand A, Beltran C, Brooks J, Cimmiyotti J, Grimaldi N, Hodge T, Hunzeker A, Lucido JJ, Laack NN, Momoh R, Moseley DJ, Patel SH, Ridgway A, Seetamsetty S, Shiraishi S, Undahl L, Foote RL. Scalable radiotherapy data curation infrastructure for deep-learning based autosegmentation of organs-at-risk: A case study in head and neck cancer. Front Oncol 2022; 12:936134. [PMID: 36106100 PMCID: PMC9464982 DOI: 10.3389/fonc.2022.936134] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Accepted: 08/03/2022] [Indexed: 12/02/2022] Open
Abstract
In this era of patient-centered, outcomes-driven and adaptive radiotherapy, deep learning is now being successfully applied to tackle imaging-related workflow bottlenecks such as autosegmentation and dose planning. These applications typically require supervised learning approaches enabled by relatively large, curated radiotherapy datasets which are highly reflective of the contemporary standard of care. However, little has been previously published describing technical infrastructure, recommendations, methods or standards for radiotherapy dataset curation in a holistic fashion. Our radiation oncology department has recently embarked on a large-scale project in partnership with an external partner to develop deep-learning-based tools to assist with our radiotherapy workflow, beginning with autosegmentation of organs-at-risk. This project will require thousands of carefully curated radiotherapy datasets comprising all body sites we routinely treat with radiotherapy. Given such a large project scope, we have approached the need for dataset curation rigorously, with an aim towards building infrastructure that is compatible with efficiency, automation and scalability. Focusing on our first use-case pertaining to head and neck cancer, we describe our developed infrastructure and novel methods applied to radiotherapy dataset curation, inclusive of personnel and workflow organization, dataset selection, expert organ-at-risk segmentation, quality assurance, patient de-identification, data archival and transfer. Over the course of approximately 13 months, our expert multidisciplinary team generated 490 curated head and neck radiotherapy datasets. This task required approximately 6000 human-expert hours in total (not including planning and infrastructure development time). This infrastructure continues to evolve and will support ongoing and future project efforts.
Collapse
Affiliation(s)
- E. Tryggestad
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
- *Correspondence: E. Tryggestad,
| | - A. Anand
- Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States
| | - C. Beltran
- Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, United States
| | - J. Brooks
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - J. Cimmiyotti
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - N. Grimaldi
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - T. Hodge
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - A. Hunzeker
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - J. J. Lucido
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - N. N. Laack
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - R. Momoh
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - D. J. Moseley
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - S. H. Patel
- Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States
| | - A. Ridgway
- Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United States
| | - S. Seetamsetty
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - S. Shiraishi
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - L. Undahl
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| | - R. L. Foote
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN, United States
| |
Collapse
|